As of September 2026 Halozyme Therapeutics has a market cap of โน1.153 Trillion. This makes Halozyme Therapeutics the world's 1813th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Aug 31st, 2026 the market cap of Halozyme Therapeutics was reported to be: